Allianz Asset Management Gmb H G1 Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $225,240 - $418,097	-20,495 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.55 - $23.75 $14,541 - $29,901	-1,259 Reduced 5.79%	20,495 $236,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $131,491 - $334,843	-13,740 Reduced 38.71%	21,754 $527,000
Q1 2020 May 14, 2020	SELL	$9.07 - $26.32 $143,387 - $416,092	-15,809 Reduced 30.81%	35,494 $391,000
Q4 2019 Feb 13, 2020	SELL	$20.54 - $31.0 $343,223 - $518,010	-16,710 Reduced 24.57%	51,303 $1.36 Million
Q3 2019 Nov 13, 2019	BUY	$22.78 - $40.58 $404,139 - $719,929	17,741 Added 35.29%	68,013 $1.68 Million
Q2 2019 Aug 08, 2019	BUY	$16.03 - $31.1 $238,301 - $462,332	14,866 Added 41.99%	50,272 $1.54 Million
Q1 2019 May 13, 2019	BUY	$14.4 - $21.45 $317,995 - $473,680	22,083 Added 165.75%	35,406 $588,000
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $219,962 - $683,869	13,323 New	13,323 $255,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.